Clinical Trial Update: Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients [Phase 2]

View source ↗

Summary

Phase 2 trial investigating esomeprazole for relief of symptoms in patients with non-ulcerative dyspepsia (indigestion).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Indigestion
• Non-ulcer Dyspepsia

Drugs mentioned

• Esomeprazole (Esomeprazole)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Indigestion | Phase 2 | Status: COMPLETED | Results posted: 2019-11-27